Andreas L. Jung
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 128 publications
Real-world data on the clinical impact of molecular tumor boards in high- and low-grade serous ovarian cancer.
Journal: Frontiers in oncology
Published: February 20, 2026
Implementing whole genome and transcriptome sequencing for cancer patients in routine healthcare: a comprehensive guide to costing.
Journal: British journal of cancer
Published: October 31, 2025
Large language models enable prognostic stratification of cancer patients using real-world clinical notes.
Journal: PLOS digital health
Published: October 30, 2025
Mutation enrichment in targeted panels flags immunotherapy-responsive POLE-driven hypermutated microsatellite-stable colorectal cancers.
Journal: NPJ precision oncology
Published: October 15, 2025
Impact of sex on efficacy and safety of 1st-line treatment with FOLFIRI plus cetuximab or bevacizumab in RAS/BRAF wildtype metastatic colorectal cancer - A subgroup analysis of the FIRE-3 (AIO KRK-0306) trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 13, 2025
Correction: Precision Oncology in Rare Endocrine and Neuroendocrine Neoplasms: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board.
Journal: Targeted oncology
Published: August 27, 2025
Precision Oncology in Rare Endocrine and Neuroendocrine Neoplasms: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board.
Journal: Targeted oncology
Published: May 04, 2025
Molecular hyperselection for optimal choice of first-line targeted therapy independent of primary tumor sidedness: An exploratory analysis of the randomized FIRE-3 study performed in RAS wild-type metastatic colorectal cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 13, 2025
Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Ter: A Case Report.
Journal: Oncology research and treatment
Published: January 26, 2025
Efficacy of CDK4/6 Inhibition in colorectal cancer and the role of p16 expression in predicting drug resistance.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: December 07, 2024
Five-Gene Expression Signature Associated With Acquired FOLFIRI Resistance and Survival in Metastatic Colorectal Cancer.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: August 15, 2024
Benchmarking whole exome sequencing in the German network for personalized medicine.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 20, 2024
Last Updated: 09/26/2026